Trial
NCT01611675
Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Massachusetts General Hospital
Collaborators
—
Condition
Melanoma
Intervention
Vemurafenib
Why stopped
Adverse Events
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-06